利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

891 条记录 (耗时 0.031 秒)

    SYRINGE WITH VISUAL USE INDICATOR
    2.
    发明公开
    SYRINGE WITH VISUAL USE INDICATOR 有权
    SPRITZE MIT VISUELLEM GEBRAUCHSINDIKATOR

    公开(公告)号：EP2362791A2

    公开(公告)日：2011-09-07

    申请号：EP10704644.3

    申请日：2010-02-04

    申请人： Mallinckrodt Inc.

    发明人： MARTZ, Kevin, R.

    IPC分类号： A61M5/145 ,  A61M5/00 ,  A61M5/31 ,  A61M5/50

    CPC分类号： A61M5/007 ,  A61B6/548 ,  A61M5/14546 ,  A61M5/3129 ,  A61M5/5086 ,  A61M2005/14553 ,  A61M2205/0227 ,  A61M2205/273 ,  A61M2205/3331 ,  A61M2205/583 ,  A61M2205/587

    摘要： Systems and methods are presented for the visual indication of whether a power injector has discharged fluid from a power injector syringe in a previous medical procedure. In this regard, the systems and methods generally provide for a power injector and a syringe for use with the power injector. The syringe includes a visual indicator (164) that moves between a first state and a second state at approximately the same time that the power injector discharges fluid from the syringe such that an operator may view the change in state.

    摘要翻译： 呈现系统和方法，用于视觉指示动力注射器是否在先前的医疗过程中从动力注射器注射器排出流体。 在这方面，系统和方法通常提供用于动力注射器的动力注射器和注射器。 注射器包括在动力注射器从注射器排出流体大致同时在第一状态和第二状态之间移动的视觉指示器（164），使得操作者可以观察状态的改变。

    Fluorescent pyrazine derivatives and methods of using the same in assessing renal function
    3.
    发明授权
    Fluorescent pyrazine derivatives and methods of using the same in assessing renal function 有权
    荧光吡嗪衍生物和肾功能的审查使用方法

    公开(公告)号：EP1854790B1

    公开(公告)日：2011-08-31

    申请号：EP07013568.6

    申请日：2005-12-22

    申请人： MALLINCKRODT, INC.

    发明人： Rajagopalan, Raghavan ,  Neumann, William L. ,  Dorshow, Richard B. ,  Moore, Dennis A.

    IPC分类号： C07D241/26 ,  A61K31/4965

    CPC分类号： C07D241/28 ,  A61K31/4965 ,  A61K49/0004 ,  A61K49/0021 ,  A61K49/0052 ,  C07D241/20 ,  C07D241/26

    摘要： The present invention relates to pyrazine derivatives such as those represented by Formulas I and II. X 1 to X 4 of Formulas I and II may be characterized as electron withdrawing groups, while Y' to Y 4 of Formulas I and II may be characterized as electron donating groups. Pyrazine derivatives of the present invention may be utilized in assessing organ (e.g., kidney) function. In a particular example, an effective amount of a pyrazine derivative that is capable of being renally cleared may be administered into a patient's body. The pyrazine derivative may capable of one or both absorbing and emanating spectral energy of at least about 400nm (e.g., visible and/or infrared light). At least some of the derivative that is in the body may be exposed to spectral energy and, in turn, spectral energy may emanate from the derivative. This emanating spectral energy may be detected and utilized to determine renal function of the patient.

    WORKFLOW DRIVEN USER INTERFACE FOR MEDICAL FLUID DELIVERY SYSTEMS
    4.
    发明公开
    WORKFLOW DRIVEN USER INTERFACE FOR MEDICAL FLUID DELIVERY SYSTEMS 审中-公开
    通过操作控制的用户接口用于药物流体系统管理

    公开(公告)号：EP2353118A1

    公开(公告)日：2011-08-10

    申请号：EP09764147.6

    申请日：2009-11-25

    申请人： Mallinckrodt Inc.

    发明人： ZIEMBA, Robert, J. ,  NEER, Charles, S.

    IPC分类号： G06F19/00

    CPC分类号： G06F19/3468 ,  A61B6/548 ,  A61M2005/3103 ,  G06F19/00

    摘要： A medical fluid delivery system (300) includes workflow construction logic (304) to create one or more workflows (307) from a plurality of available workflow components (306). The created workflows (307) may each contain a proper subset of workflow components from the plurality of available workflow components (306). The workflows (307) may be created using the workflow construction logic (304) and a user interface (302) by selecting and arranging graphical elements representing workflow components (306). The constructed workflows (307) may correspond with the practices of a given care group. The medical fluid delivery system (300) may further include workflow execution logic (305) operable to execute the workflows (307). When executed, the workflows (307) may sequentially guide a user through each of the included workflow components (306) using a fled interface. The nomenclature displayed by the workflow components (306) during workflow execution may be customizable.

    DROP-IN PIG INJECTOR
    6.
    发明公开
    DROP-IN PIG INJECTOR 有权
    滴入式注射器

    公开(公告)号：EP2347421A2

    公开(公告)日：2011-07-27

    申请号：EP09792948.3

    申请日：2009-09-24

    申请人： Mallinckrodt Inc.

    发明人： WAGNER, Gary, S.

    IPC分类号： G21F5/018 ,  A61M5/145

    CPC分类号： A61M5/1452 ,  A61M5/007 ,  A61M5/19 ,  G21F5/018

    摘要： A radiopharmaceutical containment or pig, in certain embodiments, may include a plurality of cavities or chambers to accommodate a syringe and other medical devices. For example, a syringe may be housed in a first chamber of the radiopharmaceutical containment, and a tube coupled to the syringe may be housed in a second chamber and extractable via a passage in the radiopharmaceutical containment. In some embodiments, a user may extract a radiopharmaceutical from the radiopharmaceutical containment without having to remove the syringe from the containment. The radiopharmaceutical containment may include radiation shielding, an aperture to enable a ram of a power injector to engage or interact with a syringe inside the containment, a movable shutter over the aperture, various labels, and/or an integral storage compartment.

    摘要翻译： 在某些实施例中，放射性药物容器或猪可以包括多个空腔或腔室以容纳注射器和其他医疗装置。 例如，注射器可容纳在放射性药物容器的第一腔室中，并且耦合到注射器的管可容纳在第二腔室中并且可经由放射性药物容器中的通道提取。 在一些实施例中，使用者可以从放射性药物容器中提取放射性药物，而不必从注射器中取出注射器。 放射性药物容器可以包括辐射防护装置，用于使动力注射器的柱塞能够接合安全壳内的注射器或与安全壳内的注射器相互作用的开口，位于开口上方的可移动开闭器，各种标签和/或整体式储藏室。

    POWER INJECTOR HAVING CALIBRATED PRESSURE MONITORING FUNCTIONALITY
    7.
    发明公开
    POWER INJECTOR HAVING CALIBRATED PRESSURE MONITORING FUNCTIONALITY 审中-公开
    T UNG ER ER ER T T T T T T T T T T T T T T T

    公开(公告)号：EP2347359A2

    公开(公告)日：2011-07-27

    申请号：EP09791765.2

    申请日：2009-08-21

    申请人： Mallinckrodt Inc.

    发明人： MCLEAN, Mike, W.

    IPC分类号： G06F19/00

    CPC分类号： A61M5/14546 ,  A61M5/007 ,  A61M2005/14208 ,  A61M2005/14553 ,  A61M2205/14 ,  A61M2205/3317 ,  G06F19/00 ,  G06F19/3468

    摘要： Control logic (110) for a power injector is disclosed, where this power injector control logic (110) includes a syringe fill protocol (114), a pressure calibration protocol (116), a pressure monitoring protocol (118), and an injection protocol (120). The power injector control logic (110) is configured to execute the pressure calibration protocol (116) on each execution of the syringe fill protocol (114). The pressure calibration protocol (116) updates the pressure monitoring protocol (118), which is executed during execution of the injection protocol (120).

    摘要翻译： 公开了一种用于动力注射器的控制逻辑（110），其中该动力注射器控制逻辑（110）包括注射器填充协议（114），压力校准协议（116），压力监视协议（118）和注射协议 （120）。 动力注射器控制逻辑（110）被配置为在每次执行注射器填充协议（114）时执行压力校准协议（116）。 压力校准协议（116）更新在执行注入协议（120）期间执行的压力监视协议（118）。